4.3 Article

The complement anaphylatoxin receptors are not required for the development of experimental autoimmune uveitis

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 264, Issue 1-2, Pages 127-129

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2013.08.010

Keywords

Anaphylatoxins; Complement; Experimental autoimmune uveoretinitis

Funding

  1. NIH [EY014189, NS46032]
  2. EyeSight Foundation of Alabama [FY2002-03-16]
  3. EyeSight Foundation of Alabama and Research

Ask authors/readers for more resources

To determine if complement anaphylatoxin-mediated inflammation contributes to the development and progression of experimental autoimmune uveitis (EAU), we induced disease in wild type and complement anaphylatoxin receptor-deficient mice (C3a receptor(-/-), C5a receptor(-/-)and C3alt(-/-)/C5aR(-/-)) and evaluated the eyes three weeks post-induction. No differences in disease severity or in disease incidence were seen between wild type controls and anaphylatoxin receptor-deficient mice. Our data indicate that C3a and C5a-mediated functions are not critical to the development of EAU. (C) 2013 Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

Interobserver Agreement Among Uveitis Experts on Uveitic Diagnoses: The Standardization of Uveitis Nomenclature Experience

Douglas A. Jabs, Andrew Dick, John T. Doucette, Amod Gupta, Susan Lightman, Peter McCluskey, Annabelle A. Okada, Alan G. Palestine, James T. Rosenbaum, Sophia M. Saleem, Jennifer Thorne, Brett Trusko

AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)

Review Ophthalmology

Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis Fundamentals Of Care for UveitiS (FOCUS) Initiative

Andrew D. Dick, James T. Rosenbaum, Hassan A. Al-Dhibi, Rubens Belfort, Antoine P. Brezin, Soon Phaik Chee, Janet L. Davis, Athimalaipet V. Ramanan, Koh-Hei Sonoda, Ester Carreno, Heloisa Nascimento, Sawsen Salah, Sherveen Salek, Jay Siak, Laura Steeples

OPHTHALMOLOGY (2018)

Article Ophthalmology

Rehabilitation Referral for Patients With Irreversible Vision Impairment Seen in a Public Safety-Net Eye Clinic

M. Austin Coker, Carrie E. Huisingh, Gerald McGwin, Russell W. Read, Mark W. Swanson, Laura E. Dreer, Dawn K. DeCarlo, Lindsay Gregg, Cynthia Owsley

JAMA OPHTHALMOLOGY (2018)

Article Ophthalmology

Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy

Susan D. Vogt, Christine A. Curcio, Lan Wang, Chuan-Ming Li, Gerald McGwin, Nancy E. Medeiros, Nancy J. Philp, James A. Kimble, Russell W. Read

EXPERIMENTAL EYE RESEARCH (2011)

Article Emergency Medicine

CONJUNCTIVAL ATTACHMENT OF A TICK: CLINICOPATHOLOGIC REPORT OF A CASE

Christi Willen, Gary R. Mullen, Jeff Yee, Russell W. Read

JOURNAL OF EMERGENCY MEDICINE (2011)

Article Ophthalmology

Lack of Consensus in the Diagnosis and Treatment for Ocular Tuberculosis among Uveitis Specialists

Susan M. Lou, Kelly L. Larkin, Kevin Winthrop, James T. Rosenbaum

OCULAR IMMUNOLOGY AND INFLAMMATION (2015)

Article Ophthalmology

Long-Term, Multicenter Evaluation of Subconjunctival Injection of Triamcinolone for Non-Necrotizing, Noninfectious Anterior Scleritis

Elliott H. Sohn, Robert Wang, Russell Read, Athena Roufas, Livia Teo, Ramana Moorthy, Thomas Albini, Daniel V. Vasconcelos-Santos, Laurie D. Dustin, Ehud Zamir, Soon-Phaik Chee, Peter McCluskey, Ronald Smith, Narsing Rao

OPHTHALMOLOGY (2011)

Article Ophthalmology

Ocular Toxocariasis: Epidemiologic, Anatomic, and Therapeutic Variations Based on a Survey of Ophthalmic Subspecialists

Dana Woodhall, Michelle C. Starr, Susan P. Montgomery, Jeffrey L. Jones, Flora Lum, Russell W. Read, Ramana S. Moorthy

OPHTHALMOLOGY (2012)

Article Ophthalmology

Histologic Basis of Variations in Retinal Pigment Epithelium Autofluorescence in Eyes with Geographic Atrophy

Martin Rudolf, Susan D. Vogt, Christine A. Curcio, Carrie Huisingh, Gerald McGwin, Anna Wagner, Salvatore Grisanti, Russell W. Read

OPHTHALMOLOGY (2013)

Article Ophthalmology

Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders

Grace Levy-Clarke, Douglas A. Jabs, Russell W. Read, James T. Rosenbaum, Albert Vitale, Russell N. Van Gelder

OPHTHALMOLOGY (2014)

Letter Ophthalmology

Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96) Reply

Russell W. Read, Grace Levy-Clarke, Douglas A. Jabs, James T. Rosenbaum, Albert Vitale, Russell N. Van Gelder

OPHTHALMOLOGY (2014)

Article Pediatrics

Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report

Katherine J. Donnithorne, Russell W. Read, Robert Lowe, Peter Weiser, Randy Q. Cron, Timothy Beukelman

PEDIATRIC RHEUMATOLOGY (2013)

Article Ophthalmology

Subretinal Pigment Epithelial Deposition of Drusen Components Including Hydroxyapatite in a Primary Cell Culture Model

Matthew G. Pilgrim, Imre Lengyel, Antonio Lanzirotti, Matt Newville, Sarah Fearn, Eszter Emri, Jonathan C. Knowles, Jeffrey D. Messinger, Russell W. Read, Clyde Guidry, Christine A. Curcio

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)

Article Ophthalmology

Statin use and ocular inflammatory disease risk

Jacob J. Yunker, Gerald McGwin, Russell W. Read

JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2013)

No Data Available